Quantcast

Sign Up For Email Updates:

       Please leave this field empty

From Our Blog

More from the blog »
WCRF/AICR
Global Network

Abnormal Receptor for a Vitamin A Derivative in Promyelocytic Leukemia (1994)

Title:

Abnormal Receptor for a Vitamin A Derivative in Promyelocytic Leukemia

Key words:

acute promyelocytic leukemia, retinoic acid, vitamin A, abnormal fusion protein

Research Institution:

University of Pittsburgh

Location:

Pennsylvania

Researcher:

Robert Redner

Project Description:

Based on the observation that Acute Promyelocytic Leukemia (APL) can be reversed by treatment with retinoic acid, a natural derivative of vitamin A, Dr. Redner investigated the molecular mechanism underlying the success of this therapy in APL. He sought to determine whether a specific abnormal fusion protein (NPM-RAR) interferes with the function of the normal retinoic acid receptor protein.

Cancer Site(s)

Related Foods that Fight Cancer

Questions: Ask Our Staff

Talk to us!

Our planned giving staff is
here to help you!

Ann Wrenshall Worley

Ann Wrenshall Worley

Assistant Director of Planned Giving

Call Us: (800) 843-8114

Send us a note